Only 14 randomised controlled trials examined the cost effectiveness of adherence interventions. Despite that some studies showe favourable ICERs, the overall quality of studies was modest and the economic perspectives applied were frequently narrow. To demonstrate that adherence interventions...

<Emphasis Type="Bold">Background: When national pharmacoeconomic guidelines are compared, different recommendations are identified on how to identify, measure and value lost productivity, leading to difficulties when comparing lost productivity estimates across countries. From a transferability point of view, the...</emphasis>

Objectives: In economic evaluation of health care programmes, productivity costs may be overestimated, because compensation of lost work is neglected. This study tested the conclusions of previous studies which indicated that absenteeism is often compensated for during normal work hours, thereby...

Given health budget constraints, it becomes increasingly important to determine whether implementing guidelines to change clinical practice is worthwhile. We provide a model (1) to assess the economic impact of non-adherence to guideline recommendations by patients and health care professionals...

This review found a substantial number of published cost-effectiveness analyses of drugs in osteoporosis in the last 6 years. Results and critical appraisal of these articles can help decision makers when prioritizing health interventions and can inform the development of future economic...